4//SEC Filing
LACK WALTER J 4
Accession 0001179110-12-011173
CIK 0000919722other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:49 PM ET
Size
13.5 KB
Accession
0001179110-12-011173
Insider Transaction Report
Form 4
LACK WALTER J
Director
Transactions
- Exercise/Conversion
Common Stock
2012-06-29$2.14/sh+15,000$32,100→ 395,000 total - Exercise/Conversion
Director Stock Option (Right to buy)
2012-06-29−10,000→ 0 totalExercise: $2.14Exp: 2020-06-10→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2012-06-29$2.14/sh+10,000$21,400→ 415,000 total - Exercise/Conversion
Common Stock
2012-06-29$2.14/sh+10,000$21,400→ 405,000 total - Exercise/Conversion
Director Stock Option (Right to buy)
2012-06-29−15,000→ 0 totalExercise: $2.14Exp: 2020-06-10→ Common Stock (15,000 underlying) - Exercise/Conversion
Director Stock Option (Right to buy)
2012-06-29−10,000→ 0 totalExercise: $2.14Exp: 2020-06-10→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]3,750 shares of the 15,000 share option grant became exercisable on the June 10, 2010 grant date and on each three month anniversary thereafter.
- [F2]2,500 shares of the 10,000 share option grant became exercisable on the June 10, 2010 grant date and on each three month anniversary therafter.
Documents
Issuer
Astex Pharmaceuticals, Inc
CIK 0000919722
Entity typeother
Related Parties
1- filerCIK 0001207708
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:49 PM ET
- Size
- 13.5 KB